<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists" Data-Source="WikiPathways" Version="WP5273_Dr" Last-Modified="20220909105156" Organism="Danio rerio">
  <Comment Source="WikiPathways-description">A hypothetical pathway showing the interactions of metabolites produced by the intestinal microbiome, which can affects the anticoagulant response of vitamin K antagonists (VKAs).</Comment>
  <Comment Source="ECO">ECO:0007481 - biological system reconstruction evidence based on orthology evidence used in automatic assertion</Comment>
  <Comment Source="HomologyMapper">This pathway was inferred from Homo sapiens pathway WP5273.gpml (WP5273_r123985) with a 87.0% conversion rate.</Comment>
  <BiopaxRef>e5f</BiopaxRef>
  <Graphics BoardWidth="913.6413133146343" BoardHeight="607.1924131295707" />
  <DataNode TextLabel="nr1i2" GraphId="b05db" Type="Protein">
    <Comment>AKA regnane X receptor, NR1I2</Comment>
    <Comment>PXR is a drug-activated nuclear receptor, and has been shown to mediate the transcriptional upregulation of CYP2C gene</Comment>
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:O75469</Comment>
    <Graphics CenterX="588.1867678600862" CenterY="360.29533080349796" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000029766" />
  </DataNode>
  <DataNode TextLabel="1-butyrate" GraphId="b5369" Type="Metabolite">
    <Comment>short-chain fatty acids (SCFAs); other SCFAs prodcued by the intestinal bacteria are  propionic and acetic acids.</Comment>
    <Comment>butyrate could reduce the absorption of dietary cholesterol by downregulating the expression of NPC1L1 in the intestines</Comment>
    <Comment>Butyrate is Peroxisome Proliferator-Activated Receptor (PPAR) agonist (dor both PPARα and PPARβ)</Comment>
    <Graphics CenterX="259.0331628444152" CenterY="135.37370070945397" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:17968" />
  </DataNode>
  <DataNode TextLabel="pparab" GraphId="ba0c6" Type="Protein">
    <Comment>AKA PPARA, PPARα, the peroxisome proliferator-activated receptor α</Comment>
    <Comment>activation of PPARα and PPARβ will decrease the expression of NPC1L1 in intestines</Comment>
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:Q07869</Comment>
    <Graphics CenterX="248.06137601055934" CenterY="290.54611450255743" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000054323" />
  </DataNode>
  <DataNode TextLabel="VDR" GraphId="c0dd8" Type="GeneProduct">
    <Comment>AKA vitamin D receptor</Comment>
    <Comment>VDR is a drug-activated nuclear receptor and has been shown to mediate the transcriptional upregulation of CYP2C gene.</Comment>
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:P11473</Comment>
    <Graphics CenterX="475.33410328328716" CenterY="360.29533080349796" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000112923" />
  </DataNode>
  <DataNode TextLabel="Lithocholic acid" GraphId="cb259" Type="Metabolite">
    <Comment>secondary bile acid produced by intestinal bacteria</Comment>
    <Comment>Could activate PXR (72), and is a vitamin D receptor (VDR) agonist.</Comment>
    <Graphics CenterX="453.729628407492" CenterY="135.37370070945397" Width="123.36990595611252" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16325" />
  </DataNode>
  <DataNode TextLabel="menaquinone" GraphId="d27dc" Type="Metabolite">
    <Comment>Figure in paper describes menaquinone, text mentiones: "MK-4 has been found as the most common menaquinone in humans, as well as the only menaquinone converted by phylloquinone. The other menaquinone is synthesized by some obligate and facultative anaerobic bacteria. Except for MK-4, the other menaquinone in humans is mostly synthesized by intestinal bacteria. [PMID:35510250]. Therefore, annotated with overarching Vit.K2 ID from chebi (which should constitute all subforms)</Comment>
    <BiopaxRef>e5f</BiopaxRef>
    <Graphics CenterX="693.2024418412711" CenterY="135.37370070945397" Width="108.47962382445155" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16374" />
  </DataNode>
  <DataNode TextLabel="Warfarin" GraphId="d44ec" Type="Metabolite" GroupRef="a6b35">
    <Comment>AKA Coumadin</Comment>
    <Graphics CenterX="161.7697268584111" CenterY="362.51330196712524" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32768" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:10033" />
  </DataNode>
  <DataNode TextLabel="NPC1L1" GraphId="d4a5d" Type="GeneProduct">
    <Comment>AKA NPC1like intracellular cholesterol transporter 1;</Comment>
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:Q9UHC9</Comment>
    <Graphics CenterX="588.1867678600862" CenterY="222.77181983171113" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000099558" />
  </DataNode>
  <DataNode TextLabel="Vitamin K absorption" GraphId="e4713" Type="Pathway">
    <Graphics CenterX="693.2024418412732" CenterY="191.01633393829388" Width="164.9059561128526" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" Color="14961e" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="phylloquinone" GraphId="f5214" Type="Metabolite">
    <Comment>AKA VK1</Comment>
    <Comment>NPC1L1 is a regulatory factor of intestinal phylloquinone absorption</Comment>
    <BiopaxRef>e5f</BiopaxRef>
    <Graphics CenterX="802.2071811777665" CenterY="95.65549278565676" Width="124.15360501567393" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:28433" />
  </DataNode>
  <DataNode TextLabel="CYP2C9" GraphId="f98c9" Type="GeneProduct">
    <Comment>AKA cytochrome P450 Family 2 Subfamily C Member 9.</Comment>
    <Comment Source="HomologyMapper">No homologues found for original id S:P11712</Comment>
    <Graphics CenterX="530.2768725584633" CenterY="461.0677811020149" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="cd36" GraphId="ae915" Type="GeneProduct">
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:P16671</Comment>
    <Graphics CenterX="693.2024418412732" CenterY="222.7718198317111" Width="90.0" Height="25.0" ZOrder="32769" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000032639" />
  </DataNode>
  <DataNode TextLabel="scarb1" GraphId="f1a02" Type="Protein">
    <Comment>AKA Scavenger receptor class B member 1</Comment>
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:Q8WTV0</Comment>
    <Graphics CenterX="795.4908430951956" CenterY="222.77181983171107" Width="90.0" Height="25.0" ZOrder="32770" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000101557" />
  </DataNode>
  <DataNode TextLabel="menaquinone" GraphId="ecf9b" Type="Metabolite">
    <Comment>Figure in paper describes menaquinone, text mentiones: "MK-4 has been found as the most common menaquinone in humans, as well as the only menaquinone converted by phylloquinone. The other menaquinone is synthesized by some obligate and facultative anaerobic bacteria. Except for MK-4, the other menaquinone in humans is mostly synthesized by intestinal bacteria. [PMID:35510250]. Therefore, annotated with overarching Vit.K2 ID from chebi (which should constitute all subforms)</Comment>
    <BiopaxRef>e5f</BiopaxRef>
    <Graphics CenterX="757.3011879227729" CenterY="354.6213496122749" Width="108.47962382445155" Height="25.0" ZOrder="32771" FontSize="12" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:16374" />
  </DataNode>
  <DataNode TextLabel="ppardb" GraphId="d6cca" Type="Protein">
    <Comment>AKA PPARB, PPARβ, the peroxisome proliferator-activated receptor β;  PPARbeta (formerly PPARdelta)</Comment>
    <Comment>activation of PPARα and PPARβ will decrease the expression of NPC1L1 in intestines</Comment>
    <Comment Source="HomologyMapper">Homology Mapping from Homo sapiens to Danio rerio: Original ID = S:Q03181</Comment>
    <Graphics CenterX="340.3497772644775" CenterY="330.32667876588005" Width="90.0" Height="25.0" ZOrder="32774" FontSize="12" Valign="Middle" />
    <Xref Database="Ensembl" ID="ENSDARG00000009473" />
  </DataNode>
  <DataNode TextLabel="Coumatetralyl" GraphId="aceb6" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="161.7697268584111" CenterY="387.51330196712524" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32789" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="Wikidata" ID="Q415772" />
  </DataNode>
  <DataNode TextLabel="Phenprocoumon" GraphId="ead9b" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="161.7697268584111" CenterY="412.51330196712513" Width="76.87203791469193" Height="25.0" ZOrder="32790" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:50438" />
  </DataNode>
  <DataNode TextLabel="Acenocoumarol" GraphId="a4b61" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="161.7697268584111" CenterY="437.51330196712513" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32791" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:53766" />
  </DataNode>
  <DataNode TextLabel="Apaxiban" GraphId="c2487" Type="Metabolite" GroupRef="a6b35">
    <Comment>AKA Eliquis, alternative to warfarin</Comment>
    <Graphics CenterX="84.84352509808596" CenterY="362.51330196712524" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32792" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:72296" />
  </DataNode>
  <DataNode TextLabel="dicoumarol" GraphId="c4174" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="238.5876009274698" CenterY="387.51330196712513" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32793" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:4513" />
  </DataNode>
  <DataNode TextLabel="Tioclomarol" GraphId="cb78d" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="238.5876009274698" CenterY="412.51330196712513" Width="76.87203791469193" Height="25.0" ZOrder="32794" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:135730" />
  </DataNode>
  <DataNode TextLabel="Brodifacoum" GraphId="f5595" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="238.5876009274698" CenterY="437.51330196712513" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32795" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="Wikidata" ID="Q421203" />
  </DataNode>
  <DataNode TextLabel="Pindone" GraphId="f55f0" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="161.76972685841105" CenterY="496.93781110727366" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32796" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="HMDB" ID="HMDB0256560" />
  </DataNode>
  <DataNode TextLabel="Chlorophacinone" GraphId="f8b27" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="161.76972685841105" CenterY="521.9378111072731" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32797" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="Wikidata" ID="Q413488" />
  </DataNode>
  <DataNode TextLabel="Diphacinone" GraphId="b832e" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="161.76972685841105" CenterY="546.9378111072731" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32798" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:81896" />
  </DataNode>
  <DataNode TextLabel="Anisindione" GraphId="e04dc" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="238.12043775888503" CenterY="496.93781110727366" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32799" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:133809" />
  </DataNode>
  <DataNode TextLabel="Fluindione" GraphId="efa0a" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="238.12043775888503" CenterY="521.9378111072731" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32800" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="Wikidata" ID="Q3074488" />
  </DataNode>
  <DataNode TextLabel="Phenindione" GraphId="e83a7" Type="Metabolite" GroupRef="a6b35">
    <Graphics CenterX="238.12043775888503" CenterY="546.9378111072731" Width="76.87203791469193" Height="24.99999999999997" ZOrder="32801" FontSize="8" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:8066" />
  </DataNode>
  <Interaction GraphId="id8ebffdf2">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0" Color="009966">
      <Point X="693.2024418412711" Y="147.87370070945397" GraphRef="d27dc" RelX="0.0" RelY="1.0" />
      <Point X="693.2024418412732" Y="178.51633393829388" GraphRef="e4713" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id93834066">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0">
      <Point X="363.46764730096123" Y="382.8787706109535" GraphRef="b3d4a" RelX="-1.0" RelY="0.0" />
      <Point X="285.02361988481573" Y="398.3694292521622" GraphRef="a6b35" RelX="1.0" RelY="-0.5" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idb88b530f">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="485.2768725584633" Y="461.0677811020149" GraphRef="f98c9" RelX="-1.0" RelY="0.0" />
      <Point X="439.8823407668417" Y="480.04165920996746" GraphRef="ed39a" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="b8fea">
    <Graphics ZOrder="32772" LineThickness="1.0" Color="0099ff">
      <Point X="453.729628407492" Y="147.87370070945397" GraphRef="cb259" RelX="0.0" RelY="1.0" />
      <Point X="565.6867678600862" Y="347.79533080349796" GraphRef="b05db" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="idd6ce5bb9">
    <Graphics ZOrder="32773" LineThickness="1.0" Color="0099ff">
      <Point X="453.729628407492" Y="147.87370070945397" GraphRef="cb259" RelX="0.0" RelY="1.0" />
      <Point X="475.33410328328716" Y="347.79533080349796" GraphRef="c0dd8" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="e4cfd">
    <Comment>Butyrate is Peroxisome Proliferator-Activated Receptor (PPAR) agonist (dor both PPARα and PPARβ)</Comment>
    <Graphics ZOrder="32776" LineThickness="1.0" Color="0099ff">
      <Point X="259.0331628444152" Y="147.87370070945397" GraphRef="b5369" RelX="0.0" RelY="1.0" />
      <Point X="248.06137601055934" Y="278.04611450255743" GraphRef="ba0c6" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="c571e">
    <Comment>Butyrate is Peroxisome Proliferator-Activated Receptor (PPAR) agonist (dor both PPARα and PPARβ)</Comment>
    <Graphics ZOrder="32777" LineThickness="1.0" Color="0099ff">
      <Point X="259.0331628444152" Y="147.87370070945397" GraphRef="b5369" RelX="0.0" RelY="1.0" />
      <Point X="317.8497772644775" Y="317.82667876588005" GraphRef="d6cca" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="d2de3">
    <Graphics ZOrder="32778" LineThickness="1.0">
      <Point X="703.0613760105471" Y="354.6213496122749" GraphRef="ecf9b" RelX="-1.0" RelY="0.0" />
      <Point X="633.1867678600862" Y="366.54533080349796" GraphRef="b05db" RelX="1.0" RelY="0.5" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="b5a22">
    <Graphics ZOrder="32779" LineThickness="1.0" Color="0099ff">
      <Point X="588.1867678600862" Y="347.79533080349796" GraphRef="b05db" RelX="0.0" RelY="-1.0" />
      <Point X="588.1867678600862" Y="235.27181983171113" GraphRef="d4a5d" RelX="0.0" RelY="1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ac387">
    <Graphics ZOrder="32780" LineThickness="1.0" Color="0099ff">
      <Point X="610.6867678600862" Y="347.79533080349796" GraphRef="b05db" RelX="0.5" RelY="-1.0" />
      <Point X="693.2024418412732" Y="235.2718198317111" GraphRef="ae915" RelX="0.0" RelY="1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="e1bb9">
    <Graphics ZOrder="32781" LineStyle="Broken" LineThickness="1.0" Color="009966">
      <Point X="802.2071811777665" Y="108.15549278565676" GraphRef="f5214" RelX="0.0" RelY="1.0" />
      <Point X="734.4289308694863" Y="178.51633393829388" GraphRef="e4713" RelX="0.5" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id2ce3725">
    <Comment>butyrate could reduce the absorption of dietary cholesterol by downregulating the expression of NPC1L1 in the intestines</Comment>
    <Graphics ZOrder="32783" LineThickness="1.0" Color="cc0000">
      <Point X="281.5331628444152" Y="147.87370070945397" GraphRef="b5369" RelX="0.5" RelY="1.0" />
      <Point X="543.1867678600862" Y="216.52181983171113" GraphRef="d4a5d" RelX="-1.0" RelY="-0.5" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="c0efd">
    <Comment>activation of PPARα and PPARβ will decrease the expression of NPC1L1 in intestines</Comment>
    <Graphics ZOrder="32784" LineThickness="1.0" Color="cc0000">
      <Point X="293.06137601055934" Y="290.54611450255743" GraphRef="ba0c6" RelX="1.0" RelY="0.0" />
      <Point X="543.1867678600862" Y="229.02181983171113" GraphRef="d4a5d" RelX="-1.0" RelY="0.5" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="f244b">
    <Comment>activation of PPARα and PPARβ will decrease the expression of NPC1L1 in intestines</Comment>
    <Graphics ZOrder="32785" LineThickness="1.0" Color="cc0000">
      <Point X="362.8497772644775" Y="317.82667876588005" GraphRef="d6cca" RelX="0.5" RelY="-1.0" />
      <Point X="565.6867678600862" Y="235.27181983171113" GraphRef="d4a5d" RelX="-0.5" RelY="1.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="a7561">
    <Graphics ZOrder="32786" LineThickness="1.0" Color="cc0000">
      <Point X="633.1867678600862" Y="354.04533080349796" GraphRef="b05db" RelX="1.0" RelY="-0.5" />
      <Point X="795.4908430951956" Y="235.27181983171107" GraphRef="f1a02" RelX="0.0" RelY="1.0" ArrowHead="mim-inhibition" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="ff02e">
    <Comment>PXR is a drug-activated nuclear receptor and has been shown to mediate the transcriptional upregulation of CYP2C gene.</Comment>
    <Graphics ZOrder="32787" LineThickness="1.0" Color="0099ff">
      <Point X="588.1867678600862" Y="372.79533080349796" GraphRef="b05db" RelX="0.0" RelY="1.0" />
      <Point X="552.7768725584633" Y="448.5677811020149" GraphRef="f98c9" RelX="0.5" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="d87d4">
    <Comment>VDR is a drug-activated nuclear receptor and has been shown to mediate the transcriptional upregulation of CYP2C gene.</Comment>
    <Graphics ZOrder="32788" LineThickness="1.0" Color="0099ff">
      <Point X="475.33410328328716" Y="372.79533080349796" GraphRef="c0dd8" RelX="0.0" RelY="1.0" />
      <Point X="507.7768725584633" Y="448.5677811020149" GraphRef="f98c9" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Interaction GraphId="id4c47e2d4">
    <Graphics ZOrder="32804" LineThickness="1.0">
      <Point X="395.44632028674323" Y="393.86810710384435" GraphRef="b3d4a" RelX="0.0" RelY="1.0" />
      <Point X="478.64537241944504" Y="555.213740143789" GraphRef="bb692" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
      <Anchor Position="0.5340928693421096" Shape="None" GraphId="ed39a" />
    </Graphics>
    <Xref Database="" ID="" />
  </Interaction>
  <Label TextLabel="VKA" GraphId="b3d4a">
    <Comment>AKA vitamin K antagonist VKA, anticoagulant, "group of substances that reduce blood clotting by reducing the action of vitamin K. The term "vitamin K antagonist" is technically a misnomer, as the drugs do not directly antagonise the action of vitamin K in the pharmacological sense, but rather the recycling of vitamin K." Source: [https://en.wikipedia.org/wiki/Vitamin_K_antagonist]</Comment>
    <Graphics CenterX="395.44632028674323" CenterY="382.8787706109535" Width="63.957345971563996" Height="21.978672985781714" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" />
  </Label>
  <Label TextLabel="Coumarins (4-hydroxycoumarins)&#xA;Most commonly used VKAs" GraphId="d5bae">
    <Graphics CenterX="200.93187987127476" CenterY="338.29529248845256" Width="152.3358158429248" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="8" Valign="Middle" />
  </Label>
  <Label TextLabel="Indandiones&#xA;Left: rodenticides, 'first-generation' anticoagulants.&#xA;Right: anticoagulants more toxic than warfarin, rarely used." GraphId="c0600">
    <Graphics CenterX="195.09911074466675" CenterY="466.7787048107265" Width="261.1848341232226" Height="25.0" ZOrder="32802" FillColor="ffffff" FontSize="8" Valign="Middle" />
  </Label>
  <Label TextLabel="VKA metabolites" GraphId="bb692">
    <Comment>AKA vitamin K antagonist VKA, anticoagulant, "group of substances that reduce blood clotting by reducing the action of vitamin K. The term "vitamin K antagonist" is technically a misnomer, as the drugs do not directly antagonise the action of vitamin K in the pharmacological sense, but rather the recycling of vitamin K." Source: [https://en.wikipedia.org/wiki/Vitamin_K_antagonist]</Comment>
    <Graphics CenterX="478.64537241944504" CenterY="566.2030766366798" Width="134.52606635071194" Height="21.978672985781714" ZOrder="32803" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" />
  </Label>
  <Shape TextLabel="&#xA;    Intestine" GraphId="c39ae">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="522.8897459165152" CenterY="140.2177445966012" Width="721.5031347962382" Height="168.99529780564262" ZOrder="16384" FontWeight="Bold" FontSize="16" Align="Left" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Shape TextLabel="&#xA;  Liver" GraphId="fbe31">
    <Attribute Key="org.pathvisio.CellularComponentProperty" Value="Cell" />
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="532.3674441865401" CenterY="458.33695174996444" Width="241.02911306702794" Height="99.90455850735316" ZOrder="16384" FontSize="12" Align="Left" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="a6b35" GraphId="a6b35" Style="Group" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">hepatocyte</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000182</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vitamin K deficiency bleeding</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:11249</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Human Disease Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e5f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">35510250</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Relationship Among Intestinal Bacteria, Vitamin K and Response of Vitamin K Antagonist: A Review of Evidence and Potential Mechanism</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Med (Lausanne)</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2022</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Han Yan</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yi Chen</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hong Zhu</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wei-Hua Huang</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xin-He Cai</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dan Li</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ya-Juan Lv</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Si-Zhao</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hong-Hao Zhou</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fan-Yan Luo</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wei Zhang</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xi Li</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vitamin K antagonist drug pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0002325</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">vitamin and vitamin metabolites signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001012</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">gut absorptive cell</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000677</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
  </Biopax>
</Pathway>

